Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fa-Chyi Lee

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Blood|June 5, 2002
Second response to lower-dose thalidomide in a patient with multiple myelomaFa-Chyi Lee
International Journal of Dermatology|December 1, 2011
Longterm clinical remission of oral and cutaneous pemphigus with thalidomideFa-Chyi Lee
JAMA Oncology|February 14, 2020
Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast CancerFa-Chyi Lee
Frontiers of Medicine|December 22, 2019
Medical oncology management of advanced hepatocellular carcinoma 2019: a reality checkAmy Lee, Fa-Chyi Lee
American Journal of Hematology|April 18, 2003
Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomideFa-Chyi Lee, Shakil H Merchant
Clinical Nuclear Medicine|June 20, 2002
Octreotide scans are positive in a subset of patients with hepatocellular carcinomaIan Rabinowitz, Robert Telepak, Fa-Chyi Lee
ACG Case Reports Journal|July 10, 2015
Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of LiteratureWaheed Murad, Ian Rabinowitz, Fa-Chyi Lee
Cancer Control : Journal of the Moffitt Cancer Center|July 30, 2025
Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning AnalysisBingya Ma, Kai Zheng, Fa-Chyi Lee, et al.
American Journal of Hematology|March 22, 2006
Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomideCindi R Starkey, Nancy E Joste, Fa-Chyi Lee
American Journal of Clinical Oncology|September 14, 2022
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent ImmunotherapyDalia Kaakour, Garo Hagopian, Sonia Lee, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Blood|June 5, 2002
Second response to lower-dose thalidomide in a patient with multiple myelomaFa-Chyi Lee
International Journal of Dermatology|December 1, 2011
Longterm clinical remission of oral and cutaneous pemphigus with thalidomideFa-Chyi Lee
JAMA Oncology|February 14, 2020
Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast CancerFa-Chyi Lee
Frontiers of Medicine|December 22, 2019
Medical oncology management of advanced hepatocellular carcinoma 2019: a reality checkAmy Lee, Fa-Chyi Lee
American Journal of Hematology|April 18, 2003
Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomideFa-Chyi Lee, Shakil H Merchant
Clinical Nuclear Medicine|June 20, 2002
Octreotide scans are positive in a subset of patients with hepatocellular carcinomaIan Rabinowitz, Robert Telepak, Fa-Chyi Lee
ACG Case Reports Journal|July 10, 2015
Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of LiteratureWaheed Murad, Ian Rabinowitz, Fa-Chyi Lee
Cancer Control : Journal of the Moffitt Cancer Center|July 30, 2025
Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning AnalysisBingya Ma, Kai Zheng, Fa-Chyi Lee, et al.
American Journal of Hematology|March 22, 2006
Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomideCindi R Starkey, Nancy E Joste, Fa-Chyi Lee
American Journal of Clinical Oncology|September 14, 2022
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent ImmunotherapyDalia Kaakour, Garo Hagopian, Sonia Lee, et al.
Pageof 4